The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

PCVX FINANCIAL STATEMENTS

Vaxcyte Inc — balance sheet, income statement and cash flow trends

PCVXVaxcyte Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-1 B-500 M0202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue0 $Gross Profit-865 K $ · -Infinity%Operating Income-1.2 B $ · -Infinity%Pre-tax Income-1.1 B $ · -Infinity%Net Income to Owners-1.1 B $ · -Infinity%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue0 $—
Gross Profit-865 K $—
Operating Income-1.2 B $—
EBITDA-1.1 B $—
Net Income to Owners-1.1 B $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
01 B2 B3 B202120222023202420252026

Capital Structure

Q2 2026
Total Assets3.1 B
  • Equity2.8 B $88%
  • Current Liabilities271.3 M $9%
  • Long-term Liabilities108.9 M $3%

Key Figures

YoY change
Total Assets3.1 B $-5.1%
Total Liabilities380.2 M $+62.5%
Total Equity2.8 B $-10.2%
Cash & ST Investments1.5 B $-10.5%
Total Debt115.4 M $+34.5%
Net Debt-67.7 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-1 B-500 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-1 B-500 M0-1.2 B $Operating-82.8 M $Investing1.2 B $Financing-37.1 M $Net Change

Key Figures

YoY change
Operating Cash Flow-1.2 B $—
Capital Expenditures51.8 M $-54.7%
Free Cash Flow-1.2 B $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on PCVX

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 11, 26. This content is for informational purposes only and is not investment advice.